naloxone program for schools
Private/nonpublic schools that house grades 9-12 are now eligible to receive Narcan.
Prior to submitting an application for the free two-dose carton of Adapt Pharma Narcan, be sure to review the application packet (see link to the top right of the screen) for specific information on required trainings and development of policies and standing orders.
The free Narcan doses, distributed to schools by the Department of Health, will expire May 31, 2018. This was a one-time offer from Adapt Pharma through a grant awarded to Adapt Pharma by the Clinton Foundation.
There are currently no plans to offer replacement doses.
To order replacement or additional doses of Narcan:
Adapt Pharma has provided the following information
if Pennsylvania schools wish to order additional doses of Narcan at a reduced cost. The below information is for both existing
and new schools who wish to purchase additional or replacement doses of Narcan.
purchasers, such as EMS, law enforcement and community-based naloxone
distribution programs, can complete the Direct Purchase Intake Form and be contacted by an Adapt
Customer Service Representative.Schools qualify as Direct Purchasers:
and complete the form above. If you have any questions, please call Adapt
Customer Service at 1-844-4-NARCAN (844) 462-7226
- Fax or
email the completed form to Adapt Customer Service at (484) 367-7815
customer service representative will contact you via phone within 24 hours
to let you know your documentation has been sent and is awaiting approval
Administration of Narcan (naloxone)
- The departments of Health, Education and Drug and Alcohol Programs sent a PENN*LINK to school administrators in September encouraging schools to consider establishing a naloxone program. It is recommended that schools make this determination using a team approach, consisting of the administration, solicitor, doctor and nurse(s).
As of November 19, 2015, the FDA has approved the Adapt Pharma intranasal formulation of naloxone. Access the press release here.
Updated: January 2018